- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical translation of immunomodulatory therapeutics
Authors
Keywords
Immunomodulation, Immunotherapy, Regulatory considerations, Drug delivery, Cell therapy, Antibodies, Cytokines
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 176, Issue -, Pages 113896
Publisher
Elsevier BV
Online
2021-07-27
DOI
10.1016/j.addr.2021.113896
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular vesicles versus synthetic nanoparticles for drug delivery
- (2021) Kenneth W. Witwer et al. Nature Reviews Materials
- Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
- (2021) Chao Liu et al. Journal for ImmunoTherapy of Cancer
- Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
- (2021) Agrima Mian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody–drug conjugates in solid tumors: a look into novel targets
- (2021) Carmen Criscitiello et al. Journal of Hematology & Oncology
- Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
- (2021) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
- (2021) Nawid Albinger et al. GENE THERAPY
- Industrializing engineered autologous T cells as medicines for solid tumours
- (2021) Cedrik M. Britten et al. NATURE REVIEWS DRUG DISCOVERY
- Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
- (2021) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients
- (2020) A. Algazi et al. ANNALS OF ONCOLOGY
- Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis
- (2020) Qianyi Gong et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
- (2020) Olivier J. Wouters et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies
- (2020) Pranay Bharadwaj et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
- (2020) Giulia Parisi et al. Nature Communications
- Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
- (2020) Caroline Imbert et al. Nature Communications
- Cancer immunotherapy: Pros, cons and beyond
- (2020) Shuzhen Tan et al. BIOMEDICINE & PHARMACOTHERAPY
- Critical Assessment of Pharmacokinetic Drug–Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment
- (2020) Vijayabhaskar Veeravalli et al. DRUG SAFETY
- Ozanimod: First Approval
- (2020) Yvette N. Lamb DRUGS
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
- (2020) Adi Diab et al. Cancer Discovery
- Cellular backpacks for macrophage immunotherapy
- (2020) C. Wyatt Shields et al. Science Advances
- IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
- (2020) Andreas A. Hombach et al. Cells
- Engineering the drug carrier biointerface to overcome biological barriers to drug delivery
- (2020) Joel A. Finbloom et al. ADVANCED DRUG DELIVERY REVIEWS
- Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs
- (2020) John D Isaacs et al. ANNALS OF THE RHEUMATIC DISEASES
- Dendritic cell therapy in cancer treatment; the state-of-the-art
- (2020) Mahsa Sadeghzadeh et al. LIFE SCIENCES
- Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ
- (2020) Kirsty E. Waddington et al. Frontiers in Immunology
- Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
- (2020) Troels Holz Borch et al. Journal for ImmunoTherapy of Cancer
- Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
- (2020) Daria S. Chulpanova et al. Frontiers in Cell and Developmental Biology
- Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
- (2020) Runxia Gu et al. Journal of Hematology & Oncology
- Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
- (2020) Paolo A Ascierto et al. LANCET ONCOLOGY
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Localized Interleukin-12 for Cancer Immunotherapy
- (2020) Khue G. Nguyen et al. Frontiers in Immunology
- CAR-NK cells: A promising cellular immunotherapy for cancer
- (2020) Guozhu Xie et al. EBioMedicine
- Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial
- (2020) Anne Montfort et al. CLINICAL CANCER RESEARCH
- FDA efficiency for approval process of COVID-19 therapeutics
- (2020) Christine Cassidy et al. Infectious Agents and Cancer
- De novo design of potent and selective mimics of IL-2 and IL-15
- (2019) Daniel-Adriano Silva et al. NATURE
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9
- (2019) Denise Skrombolas et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
- (2019) Steven Feins et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
- (2019) Aleksandra Musiał-Wysocka et al. CELL TRANSPLANTATION
- Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
- (2019) Kenji Tamura et al. LANCET ONCOLOGY
- RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
- (2019) Keren Yizhak et al. SCIENCE
- Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
- (2019) Noor Momin et al. Science Translational Medicine
- Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials
- (2019) Seyed Hamidreza Mahmoudpour et al. Scientific Reports
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- (2019) Jing He et al. ANNALS OF THE RHEUMATIC DISEASES
- Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
- (2019) Joseph L. Benci et al. CELL
- Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
- (2019) Barbara Willekens et al. BMJ Open
- CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
- (2019) Wenxiu Wang et al. CANCER LETTERS
- Pexidartinib: First Approval
- (2019) Yvette N. Lamb DRUGS
- Upadacitinib: First Approval
- (2019) Sean Duggan et al. DRUGS
- Cytokines in Inflammatory Disease
- (2019) Shinwan Kany et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection
- (2019) Xuan Feng et al. EBioMedicine
- Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis
- (2019) Mengying Hu et al. JOURNAL OF CONTROLLED RELEASE
- Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice
- (2019) Mintai P. Hwang et al. JOURNAL OF CONTROLLED RELEASE
- Antibodies to watch in 2020
- (2019) Hélène Kaplon et al. mAbs
- The Intriguing History of Cancer Immunotherapy
- (2019) Paula Dobosz et al. Frontiers in Immunology
- Signaling and Function of Interleukin-2 in T Lymphocytes
- (2018) Sarah H. Ross et al. Annual Review of Immunology
- Estimation of clinical trial success rates and related parameters
- (2018) Chi Heem Wong et al. BIOSTATISTICS
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
- (2018) Simon Faissner et al. CNS DRUGS
- Correlation between sex and efficacy of immune checkpoint inhibitors (PD-1 and CTLA-4 inhibitors)
- (2018) Yingcheng Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Cytokines in the Treatment of Cancer
- (2018) Kevin C. Conlon et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence
- (2018) Maria Lia Scribano WORLD JOURNAL OF GASTROENTEROLOGY
- Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
- (2018) Pengju Wang et al. Nature Communications
- Talimogene laherparepvec: First in class oncolytic virotherapy
- (2018) Robert M. Conry et al. Human Vaccines & Immunotherapeutics
- Prospects of IL-2 in Cancer Immunotherapy
- (2018) Hani Choudhry et al. Biomed Research International
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- Mechanisms of Tolerance Induction by Dendritic Cells In Vivo
- (2018) Hitoshi Hasegawa et al. Frontiers in Immunology
- The application of CAR-T cell therapy in hematological malignancies: Advantages and challenges
- (2018) Zijun Zhao et al. Acta Pharmaceutica Sinica B
- Efficacy and safety of sarilumab in patients with active rheumatoid arthritis
- (2018) Delilah McCarty et al. Therapeutic Advances in Musculoskeletal Disease
- The 2018 Nobel Prize in medicine goes to cancer immunotherapy
- (2018) Zong Sheng Guo BMC CANCER
- A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma
- (2018) Jennifer L. McQuade et al. BMC CANCER
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- Teaching an old dog new tricks: next-generation CAR T cells
- (2018) Nicholas Tokarew et al. BRITISH JOURNAL OF CANCER
- Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
- (2018) Justyna Mikuła-Pietrasik et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
- (2018) Najat Bouchkouj et al. CLINICAL CANCER RESEARCH
- Cemiplimab: First Global Approval
- (2018) Anthony Markham et al. DRUGS
- Tofacitinib for the treatment of ulcerative colitis
- (2018) Agnès Fernández-Clotet et al. Expert Review of Clinical Immunology
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
- (2017) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
- (2017) Aleksandra Adamska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
- (2017) Daniel Ontaneda et al. LANCET
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
- (2017) Ping Li et al. Frontiers in Pharmacology
- Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosis
- (2017) Hongbo Yang et al. JOURNAL OF MEDICAL ECONOMICS
- Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease
- (2017) Brett Eugene Phillips et al. Frontiers in Immunology
- Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care System
- (2017) Kimberly G. Blumenthal et al. Journal of Allergy and Clinical Immunology-In Practice
- Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
- (2017) Christian Klein et al. OncoImmunology
- Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy
- (2017) Deborah Charych et al. PLoS One
- Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system
- (2017) Nikolay Dimov et al. Scientific Reports
- Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
- (2016) Praveen K. Bommareddy et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies
- (2016) M. F. Sanmamed et al. ANNALS OF ONCOLOGY
- Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial
- (2016) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study
- (2016) Ralf Gold et al. BMC Neurology
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- Atezolizumab: First Global Approval
- (2016) Anthony Markham DRUGS
- Olaratumab: First Global Approval
- (2016) Matt Shirley DRUGS
- Daratumumab: First Global Approval
- (2016) Kate McKeage DRUGS
- The immune system
- (2016) L. B. Nicholson Essays in Biochemistry
- Advances in diagnostics for transplant rejection
- (2016) Michael Nasr et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Antigen Presentation in Transplantation
- (2016) Maria-Luisa Alegre et al. TRENDS IN IMMUNOLOGY
- Ustekinumab in treatment of Crohn’s disease: design, development, and potential place in therapy
- (2016) Parakkal Deepak et al. Drug Design Development and Therapy
- Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
- (2016) Wai-Ping Lee et al. Journal of Immunology Research
- Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation
- (2016) Angus W. Thomson et al. Frontiers in Immunology
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- FDA's Expedited Approval Mechanisms for New Drug Products
- (2015) Erin E. Kepplinger BIOTECHNOLOGY LAW REPORT
- FDA Approval Summary: Ramucirumab for Gastric Cancer
- (2015) S. J. Casak et al. CLINICAL CANCER RESEARCH
- New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis
- (2015) Clayton English et al. CLINICAL THERAPEUTICS
- Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
- (2015) Saїd Azoury et al. CURRENT CANCER DRUG TARGETS
- Eluxadoline: First Global Approval
- (2015) Karly P. Garnock-Jones DRUGS
- Talimogene Laherparepvec: First Global Approval
- (2015) Sarah L. Greig DRUGS
- Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy
- (2015) Kevin J Harrington et al. Expert Review of Anticancer Therapy
- CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma
- (2015) Gunilla Enblad et al. HUMAN GENE THERAPY
- Cytokines
- (2015) Thulasi Ramani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Mechanisms of human autoimmunity
- (2015) Michael D. Rosenblum et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy
- (2015) Lucy Lee et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients
- (2015) Helen Benham et al. Science Translational Medicine
- Engineering CAR-T cells: Design concepts
- (2015) Shivani Srivastava et al. TRENDS IN IMMUNOLOGY
- Going viral: a review of replication-selective oncolytic adenoviruses
- (2015) Christopher Larson et al. Oncotarget
- First oncolytic virus approved for melanoma immunotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Vaccines versus immunotherapy: Overview of approaches in deciding between options
- (2015) Angus G Dalgleish Human Vaccines & Immunotherapeutics
- Redox-Responsive Magnetic Nanoparticle for Targeted Convection-Enhanced Delivery of O6-Benzylguanine to Brain Tumors
- (2014) Zachary R. Stephen et al. ACS Nano
- Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction- a novel mechanism for maintaining vascular function
- (2014) Ying Shao et al. Journal of Hematology & Oncology
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression
- (2014) Wei Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19-IL2 Results in Sustained Clinical and Systemic Immunologic Responses
- (2014) B. Weide et al. Cancer Immunology Research
- Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
- (2014) Guillermo Arango Duque et al. Frontiers in Immunology
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
- (2013) Sara A. Hurvitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice
- (2013) Bin He et al. MOLECULAR BIOLOGY REPORTS
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Immunomodulatory drugs: Oral and systemic adverse effects
- (2013) A. Bascones-Martinez et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients
- (2012) Dàlia Raϊch-Regué et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
- (2012) André Ballesteros-Tato et al. IMMUNITY
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma
- (2012) T. M. Herndon et al. ONCOLOGIST
- Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
- (2012) CHIE OSHITA et al. ONCOLOGY REPORTS
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
- (2011) N. Giannoukakis et al. DIABETES CARE
- Anchoring interferon alpha to apolipoprotein A-I reduces hematological toxicity while enhancing immunostimulatory properties
- (2011) Jessica Fioravanti et al. HEPATOLOGY
- Tolerogenic dendritic cells and their potential applications
- (2011) Jim Hu et al. IMMUNOLOGY
- Comparative study of clinical grade human tolerogenic dendritic cells
- (2011) M Naranjo-Gómez et al. Journal of Translational Medicine
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages
- (2011) Wei Liao et al. NATURE IMMUNOLOGY
- Belimumab
- (2011) Iñaki Sanz et al. NATURE REVIEWS DRUG DISCOVERY
- Learning about the Safety of Drugs — A Half-Century of Evolution
- (2011) Jerry Avorn NEW ENGLAND JOURNAL OF MEDICINE
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of Therapeutic Proteins: The Use of Animal Models
- (2011) Vera Brinks et al. PHARMACEUTICAL RESEARCH
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Interface of Signal Transduction Inhibition and Immunotherapy in Melanoma
- (2010) Amber L. Shada et al. CANCER JOURNAL
- Monitoring cytokine profiles during immunotherapy
- (2010) Janet C Siebert et al. Immunotherapy
- Overview of the immune response
- (2010) David D. Chaplin JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
- (2010) Ki Y. Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of innate immune responses in autoimmune disease development
- (2009) Hanspeter Waldner AUTOIMMUNITY REVIEWS
- Immunomodulator therapy: Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins
- (2009) Susan J. Lee et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity
- (2009) Caspar Ohnmacht et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
- (2009) Aminah Jatoi et al. LUNG CANCER
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- The innate immune system in SLE: type I interferons and dendritic cells
- (2008) L Rönnblom et al. LUPUS
- Potential chemotherapy side effects: What do oncologists tell parents?
- (2008) Lisa Ysela Ramirez et al. PEDIATRIC BLOOD & CANCER
- T-cell co-stimulatory pathways in autoimmunity
- (2008) Jörg J Goronzy et al. ARTHRITIS RESEARCH & THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search